Patents by Inventor Seigo Usuki

Seigo Usuki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ganglioside epitopes for treating Guillain-Barre syndrome
    Patent number: 8513197
    Abstract: Disclosed are compositions and methods for treating Guillain-Barré syndrome (GBS) in a subject that involves neutralizing specific pathogenic anti-glycolipid antibodies in the circulation of the subject. This can involve administering to the subject a molecular mimic of a ganglioside that serves as a specific competitive inhibitor for anti-ganglioside antibodies in the circulation. Also disclosed is an animal model of GBS having anti-ganglioside antibodies in the circulation.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: August 20, 2013
    Assignee: Georgia Regents University
    Inventors: Robert Yu, Seigo Usuki
  • GM1-LIKE PEPTIDES AND USES THEREOF
    Publication number: 20130115170
    Abstract: Compositions and methods relating to interfering with the interaction of gangliosides, such as GM1, with their ligands are provided. For example, methods are provided for treating infections by blocking the infectious agent from binding with GM1 using GM1-like peptides. Also provided are methods of inhibiting ligands from binding to GM 1 on the surface of cells and for neutralizing anti-GM1 antibodies in neurological diseases.
    Type: Application
    Filed: October 19, 2012
    Publication date: May 9, 2013
    Inventors: Robert Yu, Han-Chung Wu, Seigo Usuki
  • Ganglioside Epitopes For Treating Guillain-Barre Syndrome
    Publication number: 20120294850
    Abstract: Disclosed are compositions and methods for treating Guillain-Barré syndrome (GBS) in a subject that involves neutralizing specific pathogenic anti-glycolipid antibodies in the circulation of the subject. This can involve administering to the subject a molecular mimic of a ganglioside that serves as a specific competitive inhibitor for anti-ganglioside antibodies in the circulation. Also disclosed is an animal model of GBS having anti-ganglioside antibodies in the circulation.
    Type: Application
    Filed: July 31, 2012
    Publication date: November 22, 2012
    Inventors: Robert Yu, Seigo Usuki
  • Ganglioside epitopes for treating guillain-barre syndrome
    Patent number: 8236765
    Abstract: Disclosed are compositions and methods for treating Guillain-Barré syndrome (GBS) in a subject that involves neutralizing specific pathogenic anti-glycolipid antibodies in the circulation of the subject. This can involve administering to the subject a molecular mimic of a ganglioside that serves as a specific competitive inhibitor for anti-ganglioside antibodies in the circulation. Also disclosed is an animal model of GBS having anti-ganglioside antibodies in the circulation.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: August 7, 2012
    Assignee: Medical College of Georgia Research Institute, Inc.
    Inventors: Robert Yu, Seigo Usuki
  • GANGLIOSIDE EPITOPES FOR TREATING GUILLAIN-BARRE SYNDROME
    Publication number: 20110131669
    Abstract: Disclosed are compositions and methods for treating Guillain-Barré syndrome (GBS) in a subject that involves neutralizing specific pathogenic anti-glycolipid antibodies in the circulation of the subject. This can involve administering to the subject a molecular mimic of a ganglioside that serves as a specific competitive inhibitor for anti-ganglioside antibodies in the circulation. Also disclosed is an animal model of GBS having anti-ganglioside antibodies in the circulation.
    Type: Application
    Filed: May 27, 2010
    Publication date: June 2, 2011
    Inventors: Robert Yu, Seigo Usuki
  • Agent for prevention or improvement of neuropathy comprising pre-germinated brown rice lipid fraction as an effective ingredient
    Publication number: 20080260873
    Abstract: The present invention is intended to find a novel function of a component in pre-germinated brown rice and to provide a safe and effective agent or functional food for prevention or improvement of a neuropathy or diabetic neuropathy The present invention provides an agent or functional food for prevention or improvement of a neuropathy or diabetic neuropathy including a total lipid fraction of pre-germinated brown rice as an effective ingredient.
    Type: Application
    Filed: April 23, 2007
    Publication date: October 23, 2008
    Applicant: FANCL CORPORATION
    Inventors: Seigo Usuki, Robert K. Yu, Yukihiko Ito, Keiko Morikawa, Mitsuo Kise